100 related articles for article (PubMed ID: 15199739)
21. [Details about the first medical examinations of patients with Guillain-Barré or Fisher syndromes].
Kimoto K; Nishimoto Y; Odaka M; Hirata K; Yuki N
Rinsho Shinkeigaku; 2004 Sep; 44(9):630-2. PubMed ID: 15515709
[TBL] [Abstract][Full Text] [Related]
22. Influence of critical illness on axonal loss in Guillain-Barré syndrome.
Ho D; Thakur K; Gorson KC; Ropper AH
Muscle Nerve; 2009 Jan; 39(1):10-5. PubMed ID: 19086065
[TBL] [Abstract][Full Text] [Related]
23. Falling ill with Guillain-Barré syndrome: patients' experiences during the initial phase.
Forsberg A; Ahlström G; Holmqvist LW
Scand J Caring Sci; 2008 Jun; 22(2):220-6. PubMed ID: 18489692
[TBL] [Abstract][Full Text] [Related]
24. Clinical presentation and course of childhood Guillain-Barré syndrome: a prospective multicentre study.
Korinthenberg R; Schessl J; Kirschner J
Neuropediatrics; 2007 Feb; 38(1):10-7. PubMed ID: 17607598
[TBL] [Abstract][Full Text] [Related]
25. Rehabilitation of a marathon runner with Guillain-Barré syndrome.
Fisher TB; Stevens JE
J Neurol Phys Ther; 2008 Dec; 32(4):203-9. PubMed ID: 19265762
[TBL] [Abstract][Full Text] [Related]
26. Electrophysiological signs of permanent axonal loss in a follow-up study of patients with Guillain-Barré syndrome.
Dornonville de la Cour C; Andersen H; Stålberg E; Fuglsang-Frederiksen A; Jakobsen J
Muscle Nerve; 2005 Jan; 31(1):70-7. PubMed ID: 15543551
[TBL] [Abstract][Full Text] [Related]
27. Guillain-Barré syndrome in the elderly: clinical, electrophysiological, therapeutic and outcome features.
França MC; Deus-Silva L; de Castro R; Garibaldi SG; Pfeilsticker BH; Nucci A; Marques JF
Arq Neuropsiquiatr; 2005 Sep; 63(3B):772-5. PubMed ID: 16258654
[TBL] [Abstract][Full Text] [Related]
28. Neuromuscular respiratory failure in Guillain-Barre Syndrome: evaluation of clinical and electrodiagnostic predictors.
Sundar U; Abraham E; Gharat A; Yeolekar ME; Trivedi T; Dwivedi N
J Assoc Physicians India; 2005 Sep; 53():764-8. PubMed ID: 16334619
[TBL] [Abstract][Full Text] [Related]
29. [Guillain-Barré syndrome].
Fonseca T; Cardoso T; Perdigão S; Sarmento A; Morgado R; Costa MM
Acta Med Port; 2004; 17(2):119-22. PubMed ID: 15921641
[TBL] [Abstract][Full Text] [Related]
30. Long-term impact on work and private life after Guillain-Barré syndrome.
Bernsen RA; de Jager AE; Schmitz PI; van der Meché FG
J Neurol Sci; 2002 Sep; 201(1-2):13-17. PubMed ID: 12163188
[TBL] [Abstract][Full Text] [Related]
31. Factors influencing outcome in Guillain-Barré Syndrome: comparison of plasma adsorption against other treatments.
Seta T; Nagayama H; Katsura K; Hamamoto M; Araki T; Yokochi M; Utsumi K; Katayama Y
Clin Neurol Neurosurg; 2005 Oct; 107(6):491-6. PubMed ID: 16202823
[TBL] [Abstract][Full Text] [Related]
32. Clinically diagnosed Guillain-Barre syndrome in Ile-Ife, Nigeria.
Sunmonu TA; Komolafe MA; Adewuya A; Olugbodi AA
West Afr J Med; 2008 Jul; 27(3):167-70. PubMed ID: 19256323
[TBL] [Abstract][Full Text] [Related]
33. Evolving pattern of Guillain-Barre syndrome in a community hospital in Israel.
Kushnir M; Klein C; Pollak L; Rabey JM
Acta Neurol Scand; 2008 May; 117(5):347-50. PubMed ID: 17995988
[TBL] [Abstract][Full Text] [Related]
34. The morbidity and outcome of patients with Guillain-Barré syndrome admitted to the intensive care unit.
Dhar R; Stitt L; Hahn AF
J Neurol Sci; 2008 Jan; 264(1-2):121-8. PubMed ID: 17881005
[TBL] [Abstract][Full Text] [Related]
35. Pain among children and adolescents: restrictions in daily living and triggering factors.
Roth-Isigkeit A; Thyen U; Stöven H; Schwarzenberger J; Schmucker P
Pediatrics; 2005 Feb; 115(2):e152-62. PubMed ID: 15687423
[TBL] [Abstract][Full Text] [Related]
36. Functional outcomes in patients with chronic nonmalignant pain on long-term opioid therapy.
Soin A; Cheng J; Brown L; Moufawad S; Mekhail N
Pain Pract; 2008; 8(5):379-84. PubMed ID: 18844854
[TBL] [Abstract][Full Text] [Related]
37. Tongue weakness is associated with respiratory failure in patients with severe Guillain-Barré syndrome.
Orlikowski D; Terzi N; Blumen M; Sharshar T; Raphael JC; Annane D; Lofaso F
Acta Neurol Scand; 2009 Jun; 119(6):364-70. PubMed ID: 18976323
[TBL] [Abstract][Full Text] [Related]
38. CSF tau protein: a new prognostic marker for Guillain-Barré syndrome.
Jin K; Takeda A; Shiga Y; Sato S; Ohnuma A; Nomura H; Arai H; Kusunoki S; Ikeda M; Itoyama Y
Neurology; 2006 Oct; 67(8):1470-2. PubMed ID: 17060576
[TBL] [Abstract][Full Text] [Related]
39. Disability and health-related quality of life in Guillain-Barré syndrome during the first two years after onset: a prospective study.
Forsberg A; Press R; Einarsson U; de Pedro-Cuesta J; Holmqvist LW
Clin Rehabil; 2005 Dec; 19(8):900-9. PubMed ID: 16323390
[TBL] [Abstract][Full Text] [Related]
40. [Isokinetic assessment of muscular strength in subjects with acute inflammatory demyelinating polyradiculoneuropathy].
Elmhandi L; Féasson L; Camdessanche JP; Calmels P; Gautheron V
Ann Readapt Med Phys; 2004 Jun; 47(5):209-16. PubMed ID: 15183258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
